S9 Surfactant

AccuSift
Tetronic 1307,Pluracare 1307 Prill
26316-40-5
SKU Name Unit Price Delivery QTY
BLD1307 S9 Surfactant 100G $134.3 10days
BLD1307 S9 Surfactant 500G $583.4 10days
Ethylenediamine Alkoxylate Block Copolymer

Average Molecular Weight: 18,000

HLB: >24

S9 Surfactant Pluracare 1307 Prill / Tetronic 1307 Core Applications
(1) Stabilization of Reagent Components

Targets: Enzymes, antibodies, antigens, fluorescent markers, etc.

Mechanism:

Forms micelles (low critical micelle concentration, ~0.001–0.01%) to encapsulate hydrophobic regions, reducing protein denaturation.

Mitigates interfacial stress damage during lyophilization/reconstitution (synergizes with sugar-based protectants like trehalose).

Applications:

ELISA Reagents: Protects horseradish peroxidase (HRP) activity, preventing inactivation from freeze-thaw cycles.

Chemiluminescence Reagents: Stabilizes luminescent markers (e.g., acridinium esters), reducing background signals.

(2) Anti-Interference (Reduction of Non-Specific Binding)

Targets: Lipoproteins, cell debris, fibrinogen in serum/plasma.

Mechanism:

Hydrophobic PPO chains adsorb lipids, forming micelles to "trap" them and avoid non-specific binding with detection antibodies.

PEO chains create a hydrophilic barrier, blocking protein adsorption on hydrophobic surfaces (e.g., microplates, magnetic beads).

Typical Formulations:

Immunoturbidimetric Reagents: 0.05–0.2% Tetronic 1307 + 0.1% signal enhancer BAP-1 to disperse chylomicrons in lipemic samples.

Nucleic Acid Extraction Reagents: Utilizes weak cationic properties to bind impurity proteins, improving DNA purity.

(3) Nanomaterial Dispersion

Targets: Gold nanoparticles (AuNPs), quantum dots, magnetic beads.

Mechanism:

PPO chains adsorb onto nanoparticle surfaces, while PEO chains extend outward to provide steric stabilization.

Star-shaped structure enhances steric repulsion, preventing particle aggregation (superior to linear surfactants like Tween-20).

Application Examples:

Lateral Flow Strips: 0.01–0.05% Tetronic 1307 disperses gold-labeled antibodies, improving color uniformity on test lines.

Homogeneous Immunoassays: Stabilizes fluorescent magnetic microspheres, reducing sedimentation.

(4) Lyoprotection and Reconstitution Optimization

Function: Prevents inactivation of active ingredients during lyophilization and accelerates reconstitution.

Mechanism:

Forms a glassy matrix to minimize ice crystal-induced damage to protein structures.

Facilitates rapid dispersion and reduces interfacial tension during reconstitution.

Example Formulation:

Lyophilized PCR Enzyme Mix: 1% trehalose + 0.1% Tetronic 1307 + 0.05% signal enhancer BAP-1.


Pluracare® and Tetronic® are trademarks of BASF.

Operation

Concentration Range:

General Application: 0.01% - 0.2% (w/v). Concentrations exceeding this range may lead to increased viscosity or interference with detection signals.

Compatibility Contraindications:

Avoid direct mixing with strong ionic surfactants (e.g., SDS), as this may disrupt the micelle structure.

In systems containing high salt concentrations (e.g., >0.5M NaCl), it is necessary to increase the concentration of Tetronic 1307 to maintain dispersing capability.


References